ONTO Health Accelerates U.S. and International Expansion with Acquisition of LEVY Health

ONTO Health, a prominent physician-led provider in the fertility and longevity sector, has announced the acquisition of LEVY Health, a clinical decision support software company specializing in precision diagnostics and patient intake for reproductive medicine. The deal, which was finalized on July 7, 2026, involves an undisclosed amount and is part of ONTO Health's strategy to enhance its technological infrastructure and expand its operations across the United States and the Gulf Cooperation Council (GCC) region.

The acquisition of LEVY Health is strategically significant for ONTO Health, particularly following its recent $20 million Series A funding round. LEVY Health's capabilities in clinical decision support will bolster ONTO's efforts to create a scalable, tech-enabled framework for reproductive medicine. The integration aims to meet the growing demand for personalized fertility care, as the global fertility services market is projected to grow from $42.23 billion in 2023 to an estimated $70.27 billion by 2030.

Founded by Dr. Roohi Jeelani, a double board-certified reproductive endocrinology and infertility specialist, ONTO Health focuses on combining personalized care with evidence-based medicine. The company's approach emphasizes the importance of fertility as a key indicator of overall health. With LEVY Health's advanced diagnostic tools, ONTO Health aims to empower healthcare providers to identify endocrine disorders more efficiently and streamline fertility workups, thereby improving patient outcomes and experiences.

Caroline Mitterdorfer, co-founder and CEO of LEVY Health, expressed that the merger would allow the company’s innovative tools to reach a broader network of clinics and patients. This collaboration is expected to enhance the delivery of fertility care by integrating low-complexity services into existing clinical models, fostering a distributed and collaborative care ecosystem. Both companies share a commitment to providing early access to fertility services without compromising the quality of patient care.

The acquisition of LEVY Health by ONTO Health underscores the increasing importance of technology in the fertility sector, particularly as patient expectations for personalized and efficient care continue to rise. As ONTO Health expands its footprint in the U.S. and GCC regions, the integration of LEVY Health's capabilities is likely to position the company favorably within the competitive landscape of fertility services. This transaction reflects broader market trends where technological advancements are becoming essential for healthcare providers aiming to enhance operational efficiency and improve patient outcomes in the rapidly evolving fertility services market.